The Friedrich Loeffler Institute in Germany has announced the successful testing of an experimental mRNA vaccine against foot-and-mouth disease (FMD), which could improve virus management. This vaccine uses fragments of the virus's genetic code, avoiding the need to manipulate live virus, making it safer. In tests, vaccinated cows showed no symptoms and shed less virus than unvaccinated cows. This is a significant achievement, given that foot-and-mouth disease severely affects animals but poses no risk to humans. Further studies are underway to approve the vaccine.
Sources
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Cercetătorii germani au testat cu succes un vaccin împotriva febrei aftoase. Acesta folosește tehnologia ARNm
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Latest News
22:57
Women's basketball: Romania defeated Lithuania and promoted to Division A of the U18 European Championship
22:30
The Minister of Finance, Alexandru Nazare, announces after the evaluations by Fitch and Moody's: "economic risks remain high"
21:45
A new attempt at mass migration in Ceuta and Melilla was prepared on social networks for August 15
21:16
A car got stuck between the barriers at the railway crossing on Petricani Road, while a train was approaching.
20:36
Turkey imposes restrictions on commercial vessels heading to the Black Sea due to the intensification of Russian and Ukrainian attacks.
See more news